Miranda Schmalfuhs

home / authors / miranda-schmalfuhs

Articles

Pharma Pulse 4/16/24: Diabetes Weight Loss Drugs Could Reduce Risk of MS, Walmart Health Expands in Texas & more

Pharma Pulse 4/16/24: Diabetes Weight Loss Drugs Could Reduce Risk of MS, Walmart Health Expands in Texas & more

Miranda Schmalfuhs
April 16th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/15/24: Increase in ransomware attacks to healthcare's remote access systems, The Health and Healthcare of Gen Xers & more

Pharma Pulse 4/15/24: Increase in ransomware attacks to healthcare's remote access systems, The Health and Healthcare of Gen Xers & more

Miranda Schmalfuhs
April 15th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/12/24: The Road Ahead for GenAI-Enabled/Augmented Clinical Trials, The Health and Healthcare of Boomers & more

Pharma Pulse 4/12/24: The Road Ahead for GenAI-Enabled/Augmented Clinical Trials, The Health and Healthcare of Boomers & more

Miranda Schmalfuhs
April 12th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/11/24: In Battle Over Health Care Costs, Private Equity Plays Both Sides, Psychedelic Medicine Could Fill Care Gap & more

Pharma Pulse 4/11/24: In Battle Over Health Care Costs, Private Equity Plays Both Sides, Psychedelic Medicine Could Fill Care Gap & more

Miranda Schmalfuhs
April 11th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/10/24: 7% of Patients with Cancer Participate in Research, Technologies Being Used to Enhance Trial Enrollment and Diversity & more

Pharma Pulse 4/10/24: 7% of Patients with Cancer Participate in Research, Technologies Being Used to Enhance Trial Enrollment and Diversity & more

Miranda Schmalfuhs
April 10th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/9/24: AI in Clinical Development, Patient Preferences Play Essential Part in Contraceptive Care & more

Pharma Pulse 4/9/24: AI in Clinical Development, Patient Preferences Play Essential Part in Contraceptive Care & more

Miranda Schmalfuhs
April 9th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/8/24: Cannabis Use in Oncology, J&J to Acquire Shockwave Medical & more

Pharma Pulse 4/8/24: Cannabis Use in Oncology, J&J to Acquire Shockwave Medical & more

Miranda Schmalfuhs
April 8th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/5/24: Is 2024 the Year for Psychedelic Medicine? Barriers Impacting Enrollment in Lung Cancer Trials & more

Pharma Pulse 4/5/24: Is 2024 the Year for Psychedelic Medicine? Barriers Impacting Enrollment in Lung Cancer Trials & more

Miranda Schmalfuhs
April 5th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/4/24: Baltimore Bridge Collapse Upends US Supply Chains, Can Employees Realistically Expect Any Good Jobs for 2024? & more

Pharma Pulse 4/4/24: Baltimore Bridge Collapse Upends US Supply Chains, Can Employees Realistically Expect Any Good Jobs for 2024? & more

Miranda Schmalfuhs
April 4th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/3/24: Trends Shaping the Future of Drug Development, Pharmacists Can Help Monitor Cardiometabolic Parameters in Schizophrenia & more

Pharma Pulse 4/3/24: Trends Shaping the Future of Drug Development, Pharmacists Can Help Monitor Cardiometabolic Parameters in Schizophrenia & more

Miranda Schmalfuhs
April 3rd 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/2/24: Tackling Barriers to Adopting BYOD, Lonely Men with HIV More Likely to Smoke & more

Pharma Pulse 4/2/24: Tackling Barriers to Adopting BYOD, Lonely Men with HIV More Likely to Smoke & more

Miranda Schmalfuhs
April 2nd 2024

The latest news for pharma industry insiders.

Digital Solutions & Disruptive Technologies Transforming the Future Landscape of Biopharma Manufacturing

Digital Solutions & Disruptive Technologies Transforming the Future Landscape of Biopharma Manufacturing

Miranda Schmalfuhs
April 1st 2024

In this Pharmaceutical Commerce video interview, Barry Heavey, Life Sciences Supply Chain Lead, Accenture, discusses what innovative digital solutions and disruptive technologies he sees transforming the landscape of biopharma manufacturing in the future.

Pharma Pulse 4/1/24: Uncertainties Associated with Accelerated Approval, Understanding DSCSA & more

Pharma Pulse 4/1/24: Uncertainties Associated with Accelerated Approval, Understanding DSCSA & more

Miranda Schmalfuhs
April 1st 2024

The latest news for pharma industry insiders.

The Rising Tide of Biopharma Manufacturing Costs

The Rising Tide of Biopharma Manufacturing Costs

Miranda Schmalfuhs
March 29th 2024

In this Pharmaceutical Commerce video interview, Barry Heavey, Life Sciences Supply Chain Lead, Accenture, discusses the specific factors contributing to rising manufacturing costs.

Pharma Pulse 3/29/24: Social Media Users Turn to Twitter for Guidance on Birth Control, Wider Availability of Oral Contraceptives & more

Pharma Pulse 3/29/24: Social Media Users Turn to Twitter for Guidance on Birth Control, Wider Availability of Oral Contraceptives & more

Miranda Schmalfuhs
March 29th 2024

The latest news for pharma industry insiders.

Reducing Costs and Increasing Accessibility of ADCs & Cell and Gene Therapies

Reducing Costs and Increasing Accessibility of ADCs & Cell and Gene Therapies

Miranda Schmalfuhs
March 28th 2024

In this Pharmaceutical Commerce video interview, Barry Heavey, Life Sciences Supply Chain Lead, Accenture, discusses what digital tools, beyond AI and ML, hold the most promise for reducing costs and increasing accessibility of treatments.

Pharma Pulse 3/28/24: Do Mixed Results Impact Potential Real-World Effectiveness? FDA Issues Letters Over Unapproved, Misbranded OTC Analgesic Products & more

Pharma Pulse 3/28/24: Do Mixed Results Impact Potential Real-World Effectiveness? FDA Issues Letters Over Unapproved, Misbranded OTC Analgesic Products & more

Miranda Schmalfuhs
March 28th 2024

The latest news for pharma industry insiders.

Leveraging Digital Tools to Optimize Manufacturing Processes

Leveraging Digital Tools to Optimize Manufacturing Processes

Miranda Schmalfuhs
March 27th 2024

In this Pharmaceutical Commerce video interview, Barry Heavey, Life Sciences Supply Chain Lead, Accenture, discusses how companies can leverage digital tools like artificial intelligence and machine learning to optimize manufacturing processes and ensure efficient production.

Pharma Pulse 3/27/24: What's the ROI on GenAI? Virtual Second Opinions Save Over $8,700 Per Patient & more

Pharma Pulse 3/27/24: What's the ROI on GenAI? Virtual Second Opinions Save Over $8,700 Per Patient & more

Miranda Schmalfuhs
March 27th 2024

The latest news for pharma industry insiders.

Pharma Pulse 3/26/24: Medicare to Cover Wegovy, US-China Decoupling Poses Supply Chain Risks & more

Pharma Pulse 3/26/24: Medicare to Cover Wegovy, US-China Decoupling Poses Supply Chain Risks & more

Miranda Schmalfuhs
March 26th 2024

The latest news for pharma industry insiders.

Pharma Pulse 3/25/24: The Intersection of AI & Marketing, Birth Control to Be Sold OTC & more

Pharma Pulse 3/25/24: The Intersection of AI & Marketing, Birth Control to Be Sold OTC & more

Miranda Schmalfuhs
March 25th 2024

The latest news for pharma industry insiders.

Pharma Pulse 3/22/24: More Studies by Columbia Cancer Researches Retracted, Vista.ai Appoints MedTech Veteran as CEO & more

Pharma Pulse 3/22/24: More Studies by Columbia Cancer Researches Retracted, Vista.ai Appoints MedTech Veteran as CEO & more

Miranda Schmalfuhs
March 22nd 2024

The latest news for pharma industry insiders.

Pharma Pulse 3/21/24: Should Copay Accumulators be Banned? Pharmatizing AI & more

Pharma Pulse 3/21/24: Should Copay Accumulators be Banned? Pharmatizing AI & more

Miranda Schmalfuhs
March 21st 2024

The latest news for pharma industry insiders.

Pharma Pulse 3/20/24: The DSCSA and the New Importation Policy in Florida, How Secure IS an Airplane’s Wi-Fi? & more

Pharma Pulse 3/20/24: The DSCSA and the New Importation Policy in Florida, How Secure IS an Airplane’s Wi-Fi? & more

Miranda Schmalfuhs
March 20th 2024

The latest news for pharma industry insiders.

Pharma Pulse 3/19/24: AI’s Impact on CEO/Founder Sustainability, Practical Strategies to Repel Cyber Attacks & more

Pharma Pulse 3/19/24: AI’s Impact on CEO/Founder Sustainability, Practical Strategies to Repel Cyber Attacks & more

Miranda Schmalfuhs
March 19th 2024

The latest news for pharma industry insiders.

Pharma Pulse 3/18/24: Weight-Loss Drug Through Amazon, Overcoming Gender Inequities in Health Care & more

Pharma Pulse 3/18/24: Weight-Loss Drug Through Amazon, Overcoming Gender Inequities in Health Care & more

Miranda Schmalfuhs
March 18th 2024

The latest news for pharma industry insiders.

Pharma Pulse 3/15/24: Elranatamab Maintains or Improves Symptoms of Multiple Myeloma Patients, AI Assistant for Security Products & more

Pharma Pulse 3/15/24: Elranatamab Maintains or Improves Symptoms of Multiple Myeloma Patients, AI Assistant for Security Products & more

Miranda Schmalfuhs
March 15th 2024

The latest news for pharma industry insiders.

Pharma Pulse 3/14/24: Celebrity Endorsements in Ozempic, Enhancing Transparency Between Patients and Researchers & more

Pharma Pulse 3/14/24: Celebrity Endorsements in Ozempic, Enhancing Transparency Between Patients and Researchers & more

Miranda Schmalfuhs
March 14th 2024

The latest news for pharma industry insiders.

Pharma Pulse 3/13/24: Navigating the Mental Health Challenges of Cancer, Putting Menopause Medication on the Main Stage & more

Pharma Pulse 3/13/24: Navigating the Mental Health Challenges of Cancer, Putting Menopause Medication on the Main Stage & more

Miranda Schmalfuhs
March 13th 2024

The latest news for pharma industry insiders.

Adopting New Manufacturing Technologies

Adopting New Manufacturing Technologies

Miranda Schmalfuhs
March 12th 2024

A sit-down with Groovy Singh, CEO of Bright Green Corporation, who describes the waves in the global supply chain the company is making after being authorized to grow cannabis, along with cannabis-related products.

<1
...
345678>

Latest Updated Articles

Trade & Channel Strategies 2024: A GTN Bubble Balancing Act
Published: December 16th 2024 | Updated: December 30th 2024
Trade & Channel Strategies 2024: A GTN Bubble Balancing Act
The Gap in DSCSA Readiness
Published: December 9th 2024 | Updated: December 30th 2024
The Gap in DSCSA Readiness
Beyond the Finish Line: Why Post-Approval Regulatory Strategy Matters
Published: September 16th 2024 | Updated: December 30th 2024
Beyond the Finish Line: Why Post-Approval Regulatory Strategy Matters
Measuring Time Burdens Around Cancer Care
Published: December 4th 2024 | Updated: December 30th 2024
Measuring Time Burdens Around Cancer Care
Adragos Pharma Acquires Baccinex, Growing Sterile Manufacturing Services
Published: November 29th 2024 | Updated: December 30th 2024
Adragos Pharma Acquires Baccinex, Growing Sterile Manufacturing Services
Skills Needed to Thrive in the Evolving Industry Landscape
Published: November 22nd 2024 | Updated: December 30th 2024
Skills Needed to Thrive in the Evolving Industry Landscape
© 2024 MJH Life Sciences

All rights reserved.